SRI Krishna Pharmaceuticals Limited Aspirin Export Data — India (DGFT 2022–2026)

Name: SRI Krishna Pharmaceuticals Limited Aspirin Export Records India — #9 Exporter, 22 Shipments, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Aspirin

India Pharmaceutical Trade Intelligence

$37.8M327 Suppliers121 CountriesHS 30049062

ExportsIndia → SOUTH AFRICA32.4%India → UNITED STATES26.6%

ImportsCHINA → India$36.0M GERMANY → India$8.5K

#1 Supplier: RECKITT BENCKISER #1 Buyer: RECKITT BENCKISER

SRI Krishna Pharmaceuticals Limited — Aspirin Exporter #9 | $1.1M Trade Value | TransData Nexus | TransData Nexus

SRI Krishna Pharmaceuticals Limited — Aspirin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Aspirin · $1.1M export value · DGFT Verified

SRI Krishna Pharmaceuticals Limited is the #9 Indian exporter of Aspirin with $1.1M in export value and 22 verified shipments. SRI Krishna Pharmaceuticals Limited holds a 2.9% market share in Aspirin exports across 4 countries. The company exports 6 pharmaceutical products worth $31.4M across 3 therapeutic categories.

SRI Krishna Pharmaceuticals Limited — Aspirin Export Profile: Buyers & Destinations

SRI Krishna Pharmaceuticals Limited Aspirin export treemap — buyers and destination countries | TransData Nexus

Where Does SRI Krishna Pharmaceuticals Limited Export Aspirin?

Country	Value	Shipments	Share
ALGERIA	$525.7K	11	76.6%
UNITED ARAB EMIRATES	$113.4K	7	16.5%
UNITED KINGDOM	$47.5K	2	6.9%
GUYANA	$49	2	0.0%

Who Are the Top Buyers of Aspirin from SRI Krishna Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO SARL LABORATOIRES BEKER CITE AISSATIDIR VILLA	ALGERIA	$50.0K	1
TO SARL	ALGERIA	$50.0K	1
SARL LABORATOIRES BEKER	ALGERIA	$25.7K	1
ADCAN PHARMA	UNITED ARAB EMIRATES	$15.9K	3
MOBIUS LABORATORIES LTD	UNITED KINGDOM	$15.6K	1

SRI Krishna Pharmaceuticals Limited supplies Aspirin to 5 buyers globally. The largest buyer is TO SARL LABORATOIRES BEKER CITE AISSATIDIR VILLA (ALGERIA), followed by TO SARL (ALGERIA) and SARL LABORATOIRES BEKER (ALGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Aspirin Formulations Does SRI Krishna Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
ASPIRIN GRANULES DC 90%[KRISOASP-90M]	$150.0K	3
ASPIRIN GRANULES DC 90% (KRISOASP-90M)	$75.7K	2
ASPIRIN GRANULES DC GRADE ASPIRIN GRANULES DC 90%	$50.0K	1
ASPIRIN GRANULES DC GRADE ASPIRIN GRANULES DC 90%[KRISOASP-90M]	$50.0K	1
ASPIRIN GRANULES DC GRADE (ASPIRIN GRANULES DC 90%) [KRISOASP-90M]KGS	$50.0K	1
ASPIRIN GRANULES DC GRADE (ASPIRIN GRANULES DC 90%) [KRISOASP-90M]	$50.0K	1
ASPIRIN GRANULES DC GRADE)(ASPIRIN GRANULES DC 90%)[KRISOASP-90M]	$50.0K	1
ASPIRIN GRANULES DC GRADE ASPIRIN GRANULES DC 90%[KRISOPAP-90M]	$50.0K	1
ASPIRIN GRANULES DC GRADE ASPIRIN GRANULES DC 90 KRISOPAP 90M	$50.0K	1
ASPIRIN 75MG TAB(2X14S PACK)RUDIPHARM/UK(QTY:210048 PCS)(TOT TABS:5881344 NOS)	$31.9K	1

SRI Krishna Pharmaceuticals Limited exports 17 distinct Aspirin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ASPIRIN GRANULES DC 90%[KRISOASP-90M] with 3 shipments worth $150.0K.

How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Aspirin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	MEDREICH LIMITED	$1.2M	141	4	$8.5K
13	INTAS PHARMACEUTICALS LIMITED	$1.2M	69	4	$17.2K
9	SRI KRISHNA PHARMACEUTICALS LIMITED ★	$1.1M	22	4	$50.0K
14	GRANULES INDIA LIMITED	$1.1M	57	1	$19.0K
8	PAR FORMULATIONS PRIVATE LIMITED	$700.0K	14	1	$50.0K

SRI Krishna Pharmaceuticals Limited ranks #9 among 327 Indian Aspirin exporters. Average shipment value of $50.0K compared to the market average of $72.4K. The closest competitors by value are MEDREICH LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Aspirin Exports?

Port	Shipments	% Share
BANGALORE ICD	426	12.4%
SAHAR AIR	424	12.4%
SAHAR AIR CARGO ACC (INBOM4)	373	10.9%
NHAVA SHEVA SEA (INNSA1)	348	10.2%
JNPT/ NHAVA SHEVA SEA	159	4.6%
JNPT	124	3.6%
Bombay Air	107	3.1%
BANGALORE ICD (INWFD6)	104	3.0%

Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Aspirin Exports

Recent geopolitical tensions, notably the Israel-Iran conflict, have disrupted key shipping routes such as the Red Sea, leading to increased freight costs and extended transit times for Indian pharmaceutical exporters. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has highlighted potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. For SKPL, which relies on timely deliveries to maintain product efficacy, these logistical challenges necessitate strategic adjustments, including exploring alternative shipping routes and bolstering regional distribution networks.

In the US market, recent tariff implementations have introduced additional complexities for Indian exporters. While generic drugs have been exempted from certain tariffs, the overall trade environment remains uncertain. SKPL must remain vigilant, monitoring policy shifts and adapting its export strategies accordingly to maintain its competitive edge.

The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, presents new opportunities for SKPL in European markets. By eliminating or reducing tariffs on pharmaceutical products, the agreement facilitates smoother market entry, allowing SKPL to expand its footprint in EFTA member countries.

SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with bodies like the US FDA increasing inspections to ensure compliance with Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining consistent quality standards. Instances of substandard products have prompted calls for stricter oversight. For SKPL, maintaining rigorous quality control measures and staying abreast of evolving regulatory requirements are imperative to sustain its export credentials and market reputation.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Aspirin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SRI Krishna Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 22 individual customs records matching SRI Krishna Pharmaceuticals Limited exporting Aspirin, covering 17 formulations to 4 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 805+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Aspirin

Aspirin

SRI Krishna Pharmaceuticals Limited — Aspirin Exporter Profile

SRI Krishna Pharmaceuticals Limited — Aspirin Export Profile: Buyers & Destinations

Where Does SRI Krishna Pharmaceuticals Limited Export Aspirin?

Who Are the Top Buyers of Aspirin from SRI Krishna Pharmaceuticals Limited?

What Is India's Total Aspirin Export Value and How Much Does SRI Krishna Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for SRI Krishna Pharmaceuticals Limited's Aspirin Exports?

How Does SRI Krishna Pharmaceuticals Limited Compare to Other Indian Aspirin Exporters?

What Aspirin Formulations Does SRI Krishna Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Aspirin to Key Markets

United Kingdom — MHRA

How Does SRI Krishna Pharmaceuticals Limited Compare to Nearest Aspirin Exporters?

Which Indian Ports Ship Aspirin Exports?

What Other Analgesics & Antipyretics Products Does SRI Krishna Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on SRI Krishna Pharmaceuticals Limited's Aspirin Exports

SRI Krishna Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About SRI Krishna Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Aspirin Export Data from SRI Krishna Pharmaceuticals Limited

Aspirin Stats

Company Overview

Top Products by SRI Krishna Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source